468 related articles for article (PubMed ID: 25158999)
1. Management of hepatocellular carcinoma.
Fitzmorris P; Shoreibah M; Anand BS; Singal AK
J Cancer Res Clin Oncol; 2015 May; 141(5):861-76. PubMed ID: 25158999
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of antiviral therapy in patients with advanced hepatitis B virus-related hepatocellular carcinoma treated with sorafenib.
Zhang P; Yang Y; Wen F; Wheeler J; Fu P; Li Q
J Gastroenterol Hepatol; 2016 Dec; 31(12):1978-1985. PubMed ID: 27118432
[TBL] [Abstract][Full Text] [Related]
3. Sorafenib and entecavir: the dioscuri of treatment for advanced hepatocellular carcinoma?
D'Angelo S; Secondulfo M; De Cristofano R; Sorrentino P
World J Gastroenterol; 2013; 19(14):2141-3. PubMed ID: 23599639
[TBL] [Abstract][Full Text] [Related]
4. Exceptional serological and radiological response to sorafenib in 2 patients with advanced hepatocellular carcinoma and chronic hepatitis C viral infection: case report and review of the literature.
Atkin C; Earwaker P; Pallan A; Shetty S; Punia P; Ma YT
BMC Gastroenterol; 2017 Feb; 17(1):30. PubMed ID: 28193171
[TBL] [Abstract][Full Text] [Related]
5. Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib.
Cho HJ; Kim SS; Nam JS; Oh MJ; Kang DR; Kim JK; Lee JH; Kim B; Yang MJ; Hwang JC; Lim SG; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
Cytokine; 2017 Jul; 95():118-125. PubMed ID: 28260649
[TBL] [Abstract][Full Text] [Related]
6. Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma.
Gish RG; Finn RS; Marrero JA
Clin Adv Hematol Oncol; 2013 Apr; 11 Suppl 5():1-22; quiz 2 p following p22. PubMed ID: 23881427
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib.
Lim S; Han J; Kim GM; Han KH; Choi HJ
J Gastroenterol Hepatol; 2015 Jun; 30(6):1024-31. PubMed ID: 25611175
[TBL] [Abstract][Full Text] [Related]
8. The anti-viral effect of sorafenib in hepatitis C-related hepatocellular carcinoma.
Cabrera R; Limaye AR; Horne P; Mills R; Soldevila-Pico C; Clark V; Morelli G; Firpi R; Nelson DR
Aliment Pharmacol Ther; 2013 Jan; 37(1):91-7. PubMed ID: 23094860
[TBL] [Abstract][Full Text] [Related]
9. Is the efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age?
Cabibbo G; Maida M; Cammà C; Craxì A
Expert Rev Anticancer Ther; 2013 Dec; 13(12):1355-61. PubMed ID: 24224926
[TBL] [Abstract][Full Text] [Related]
10. Impact of Hepatitis C Virus Eradication on the Clinical Outcome of Patients with Hepatitis C Virus-Related Advanced Hepatocellular Carcinoma Treated with Sorafenib.
Kawaoka T; Aikata H; Teraoka Y; Inagaki Y; Honda F; Hatooka M; Morio K; Morio R; Kobayashi T; Nagaoki Y; Nakahara T; Hiramatsu A; Tsuge M; Imamura M; Kawakami Y; Chayama K
Oncology; 2017; 92(6):335-346. PubMed ID: 28245484
[TBL] [Abstract][Full Text] [Related]
11. Advanced hepatocellular carcinoma: A regional cancer center experience of 48 cases.
Lokesh KN; Chaudhuri T; Lakshmaiah KC; Babu KG; Dasappa L; Jacob LA; Suresh Babu MC; Rudresha AH; Rajeev LK
Indian J Cancer; 2017; 54(3):526-529. PubMed ID: 29798951
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma review: current treatment, and evidence-based medicine.
Raza A; Sood GK
World J Gastroenterol; 2014 Apr; 20(15):4115-27. PubMed ID: 24764650
[TBL] [Abstract][Full Text] [Related]
13. To treat or not to treat - Successful hepatitis C virus eradication in a patient with advanced hepatocellular carcinoma and complete response to sorafenib.
Waidmann O; Peveling-Oberhag J; Eichler K; Schulze F; Vermehren J
Z Gastroenterol; 2017 Jun; 55(6):564-568. PubMed ID: 27806410
[No Abstract] [Full Text] [Related]
14. Adjuvant therapy after curative treatment for hepatocellular carcinoma.
Kudo M
Oncology; 2011; 81 Suppl 1():50-5. PubMed ID: 22212936
[TBL] [Abstract][Full Text] [Related]
15. A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib.
Yang Y; Wen F; Li J; Zhang P; Yan W; Hao P; Xia F; Bi F; Li Q
Liver Int; 2015 Sep; 35(9):2147-54. PubMed ID: 25676812
[TBL] [Abstract][Full Text] [Related]
16. Can sorafenib increase survival for recurrent hepatocellular carcinoma after liver transplantation? A pilot study.
Alsina AE; Makris A; Nenos V; Sucre E; Arrobas J; Franco E; Kemmer N
Am Surg; 2014 Jul; 80(7):680-4. PubMed ID: 24987900
[TBL] [Abstract][Full Text] [Related]
17. Selection and management of hepatocellular carcinoma patients with sorafenib: recommendations and opinions from an Italian liver unit.
D'Angelo S; Secondulfo M; De Cristofano R; Sorrentino P
Future Oncol; 2013 Apr; 9(4):485-91. PubMed ID: 23560372
[TBL] [Abstract][Full Text] [Related]
18. mRECIST response combined with sorafenib-related adverse events is superior to either criterion alone in predicting survival in HCC patients treated with TACE plus sorafenib.
Wang W; Bai W; Wang E; Zhao Y; Liu L; Yang M; Cai H; Xia D; Zhang L; Niu J; Yin Z; Zhang Z; Fan D; Xia J; Han G
Int J Cancer; 2017 Jan; 140(2):390-399. PubMed ID: 27681592
[TBL] [Abstract][Full Text] [Related]
19. Recurrence-free survival of a hepatocellular carcinoma patient with tumor thrombosis of the inferior vena cava after treatment with sorafenib and hepatic resection.
Nakamura K; Beppu T; Hayashi H; Okabe H; Imai K; Nitta H; Chikamoto A; Ishiko T; Sasaki M; Baba H
Int Surg; 2015 May; 100(5):908-14. PubMed ID: 26011214
[TBL] [Abstract][Full Text] [Related]
20. Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial.
Gandhi M; Choo SP; Thng CH; Tan SB; Low AS; Cheow PC; Goh AS; Tay KH; Lo RH; Goh BK; Wong JS; Ng DC; Soo KC; Liew WM; Chow PK;
BMC Cancer; 2016 Nov; 16(1):856. PubMed ID: 27821083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
